Literature DB >> 17898071

Evidence for a multiprotein gamma-2 herpesvirus entry complex.

Laurent Gillet1, Philip G Stevenson.   

Abstract

Herpesviruses use multiple virion glycoproteins to enter cells. How these work together is not well understood: some may act separately or they may form a single complex. Murine gammaherpesvirus 68 (MHV-68) gB, gH, gL, and gp150 all participate in entry. gB and gL are involved in binding, gB and gH are conserved fusion proteins, and gp150 inhibits cell binding until glycosaminoglycans are engaged. Here we show that a gH-specific antibody coprecipitates gB and thus that gH and gB are associated in the virion membrane. A gH/gL-specific antibody also coprecipitated gB, implying a tripartite complex of gL/gH/gB, although the gH/gB association did not require gL. The association was also independent of gp150, and gp150 was not demonstrably bound to gB or gH. However, gp150 incorporation into virions was partly gL dependent, suggesting that it too contributes to a single entry complex. gp150- and gL- gp150- mutants bound better than the wild type to B cells and readily colonized B cells in vivo. Thus, gp150 and gL appear to be epithelial cell-adapted accessories of a core gB/gH entry complex. The cell binding revealed by gp150 disruption did not require gL and therefore seemed most likely to involve gB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898071      PMCID: PMC2169126          DOI: 10.1128/JVI.01141-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Kinetic and phenotypic changes in murine lymphocytes infected with murine gammaherpesvirus-68 in vitro.

Authors:  Bernadette M Dutia; James P Stewart; Robert A E Clayton; Heather Dyson; Anthony A Nash
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

2.  Assembly and organization of glycoproteins B, C, D, and H in herpes simplex virus type 1 particles lacking individual glycoproteins: No evidence for the formation of a complex of these molecules.

Authors:  G Rodger; J Boname; S Bell; T Minson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 3.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

Review 4.  Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis.

Authors:  J P Simas; S Efstathiou
Journal:  Trends Microbiol       Date:  1998-07       Impact factor: 17.079

5.  An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene.

Authors:  D A Persons; M G Mehaffey; M Kaleko; A W Nienhuis; E F Vanin
Journal:  Blood Cells Mol Dis       Date:  1998-06       Impact factor: 3.039

6.  Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect.

Authors:  X Wang; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome.

Authors:  H Adler; M Messerle; M Wagner; U H Koszinowski
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Epstein-Barr virus that lacks glycoprotein gN is impaired in assembly and infection.

Authors:  C M Lake; L M Hutt-Fletcher
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo.

Authors:  P G Stevenson; P C Doherty
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Characterization of murine gammaherpesvirus 68 glycoprotein B.

Authors:  Filipa B Lopes; Susanna Colaco; Janet S May; Philip G Stevenson
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  18 in total

Review 1.  Prospects of a novel vaccination strategy for human gamma-herpesviruses.

Authors:  Ting-Ting Wu; Marcia A Blackman; Ren Sun
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  Glycoprotein L sets the neutralization profile of murid herpesvirus 4.

Authors:  Laurent Gillet; Marta Alenquer; Daniel L Glauser; Susanna Colaco; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

3.  Murid herpesvirus-4 lacking thymidine kinase reveals route-dependent requirements for host colonization.

Authors:  Michael B Gill; Debbie E Wright; Christopher M Smith; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

4.  Glycoprotein B switches conformation during murid herpesvirus 4 entry.

Authors:  Laurent Gillet; Susanna Colaco; Philip G Stevenson
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

5.  In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection.

Authors:  Laurent Gillet; Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

6.  Herpes simplex virus gD forms distinct complexes with fusion executors gB and gH/gL in part through the C-terminal profusion domain.

Authors:  Tatiana Gianni; Michele Amasio; Gabriella Campadelli-Fiume
Journal:  J Biol Chem       Date:  2009-04-22       Impact factor: 5.157

7.  The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects.

Authors:  Bénédicte Machiels; Céline Lété; Katalin de Fays; Jan Mast; Benjamin Dewals; Philip G Stevenson; Alain Vanderplasschen; Laurent Gillet
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

8.  Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivo.

Authors:  Romana Ruiss; Shinji Ohno; Beatrix Steer; Reinhard Zeidler; Heiko Adler
Journal:  Virol J       Date:  2012-06-09       Impact factor: 4.099

9.  Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization.

Authors:  Janet S May; Philip G Stevenson
Journal:  J Gen Virol       Date:  2010-06-02       Impact factor: 3.891

10.  Antibody limits in vivo murid herpesvirus-4 replication by IgG Fc receptor-dependent functions.

Authors:  Debbie E Wright; Susanna Colaco; Camilo Colaco; Philip G Stevenson
Journal:  J Gen Virol       Date:  2009-07-22       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.